Kessler Investment Group LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 9,937 shares of the medical equipment provider's stock, valued at approximately $4,921,000. Intuitive Surgical comprises about 2.4% of Kessler Investment Group LLC's investment portfolio, making the stock its 22nd largest holding.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $25,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $28,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $26,000. Global Financial Private Client LLC boosted its stake in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the period. Finally, Summit Securities Group LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms recently commented on ISRG. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Robert W. Baird reduced their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. Citigroup reissued a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Piper Sandler decreased their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $588.95.
View Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Stock Performance
NASDAQ:ISRG traded down $0.48 during midday trading on Friday, reaching $533.71. 2,014,026 shares of the stock traded hands, compared to its average volume of 1,675,502. The stock has a market capitalization of $191.29 billion, a PE ratio of 78.26, a price-to-earnings-growth ratio of 5.67 and a beta of 1.67. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00. The business has a 50-day moving average of $532.08 and a two-hundred day moving average of $536.80.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the business posted $1.50 EPS. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president now owns 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by insiders.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.